Guillain-Barré syndrome

Guillain-Barré syndrome is a rare autoimmune disorder that causes the body’s immune system to attack the nerves.

Annexon Biosciences GBS campaign
Marketing

Annexon rolls out Guillain-Barré awareness campaign for HCPs

As it advances a monoclonal antibody targeting Guillain-Barré syndrome, Annexon is embarking on another effort to improve treatment of the condition.
Andrea Park Apr 9, 2025 12:13pm
RSV respiratory syncytial virus

FDA requires Pfizer, GSK to add new warning label on RSV shots

Jan 8, 2025 11:57am